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Abstract
As a supplement to our lead editorial, the editors of the new journal, Epidemiologic Perspectives &
Innovations, provide a partial list of specific analyses and topic areas they would like to see submitted
to the journal.
In our lead editorial [1], the editors of Epidemiologic Per-
spectives & Innovations (EP&I) present the underlying goals
and philosophy of the journal, along with the types of
articles we hope to publish. Here we clarify our goals with
some specific ideas about articles we would like to see
submitted to EP&I and with a "wish list" of methodologi-
cal research and selected other innovations and perspec-
tives we believe the field needs.
This list is far from complete, and we want to emphasize
that our intention is not to discourage submissions on
topics not specifically mentioned here. EP&I welcomes
submissions of any papers in and of epidemiology, with
the exception of those that solely report research results.
"In and of" epidemiology includes papers about epidemi-
ology and those grounded in other disciplines that might
be useful for epidemiology. Many of our articles will be
highly quantitative, but non-quantitative analyses are also
welcome. We welcome submissions whose premises
about how the field should be advancing differ from those
of this editorial.
Bridging the gap
EP&I  hopes to help bridge the gap from best-practice
methods to epidemiologic practice and teaching, and
from there to epidemiology-based decision making.
There is a gap between what methodologists know about
doing epidemiology and standard epidemiologic practice.
We believe that narrowing this gap is as important as the
development of new methodological ideas. Papers that
would narrow this gap are encouraged. These could take
different forms, including: clear presentations of
advanced methods that are underutilized (perhaps writ-
ten as tutorials or applications), surveys of epidemiologic
practice to assess where the gaps might be, papers that
function as advanced textbook chapters, and teaching arti-
cles. We will give the highest priority to papers that
achieve excellence in explanation.
On a similar note, we would like to publish methods arti-
cles that fall into the category we call, "Don't Reinvent the
Wheel." Other fields have different sets of methods that
could be useful to epidemiologists, including observa-
tional methods from econometrics and related social sci-
ences, uncertainty analysis methods from engineering and
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business, and historical perspectives from sciences with a
longer history.
Also on this theme, we plan to commission updates to
classic methods papers from the original authors. Meth-
odological knowledge is ever advancing, and it would be
interesting and useful to see what changes an author
would make to a must-read paper if that paper were writ-
ten today. We welcome suggestions of candidates for this
series.
At the other end of the bridge, we invite methods and
teaching papers that show how quantitative health
researchers can present results that are more decision-rel-
evant. We are especially interested in methods that go
beyond statistical measures that emphasize merely
whether an elevated risk has been found to ones that
emphasize how much we ought to care about that ele-
vated risk.
New methodology
The editors of EP&I have identified several specific meth-
odological areas that we believe need attention. Without
intending to restrict methodology submissions to these
topics, we are particularly interested in submissions that
deal with: (1) full and proper disclosure of uncertainty in
study results, (2) decision-making in the face of this full
disclosure, (3) identification and control of confounding,
(4) quantifying the effect of random error on study
results, and (5) specification error (i.e., artifacts of statisti-
cal methods).
Papers that fall into category (1) have begun to appear in
the epidemiologic literature [2-11] but much work
remains to be done. For example, we especially encourage
papers that deal with the specification of probability dis-
tributions for uncertainty-model parameters ("priors"),
dependencies between priors, and uncertainty-analysis
models for complicated (but realistic) situations.
While some fields have many papers that fall into category
(2), including clinical decision making, there are very few
in the epidemiologic literature.
As a fundamental challenge for causal inference and a
potential source of error in all observational study results,
confounding is, and perhaps will always be, a thorn in the
side of observational epidemiology [12]. Papers that fall
into category (3) continue to be published in the epidemi-
ologic and statistical literature [13,14], but no completely
satisfying method has emerged.
Questions of how to think about, and quantify the effect
of, random error in nonrandomized studies remain unre-
solved. A standard analysis pretends that researchers or
nature randomized the study exposure to study subjects
[15,10]. Is this the best we can do?
Study results are a function of both the data being ana-
lyzed and assumptions made in the process of the analysis
[16-18]. But surprisingly little attention has been paid in
the epidemiologic literature to category (5), the impact of
incorrect statistical assumptions on study results. Vanden-
broucke's [19] question, "Should we abandon statistical
modeling altogether?" and Greenland's [10] question,
"Are conventional statistics anything other than mislead-
ing?" deserve serious attention.
Philosophies of the science
There is a substantial amount of epistemologic discussion
in epidemiology, mostly relating to how we know if we
are seeing a causal relationship and, to a lesser extent,
what causation means. We hope that scientists in the field
will become more actively engaged in practical epistemol-
ogy (and learn to recognize such inquiry as valid scholarly
analysis, rather than commentary), and we invite them to
submit their work to EP&I. Epistemology in health science
is often treated as a matter of statistical rules of thumb,
with litigation serving as the ultimate arbiter. Neither sta-
tistical rules nor the results of lawsuits that go to trial are
a particularly good source of knowledge.
Also falling under the broad category of philosophy is
analysis of ethics. In the health sciences, such discussion
is dominated by the issue of protecting human research
subjects and patients. What is largely missing, and what
we would like to invite submissions about, is the ethics of
the core of our science: study design, data analysis, and
result reporting. Since it is impossible to report every
result that might be gleaned from a dataset, what consti-
tutes an ethical choice of what to present? This question is
central to most everything that most epidemiologists do,
and yet there is remarkably little discussion about it [20].
How many results need to be presented to justify the
social expense of doing the research? Should we consider
unethical the reporting of results in ways that make them
seem larger or more important?
Many epidemiologists consider the field per se to include
policy advocacy based on health science findings.
Whether or not one takes that position, discussions of and
about epidemiology should address questions of what
society ought to do with our findings. (If we do not bring
careful analysis to such questions, who will?) One inter-
esting and timely set of questions involves the relative
merits of decision-analysis or risk-analysis based deci-
sions, "precautionary-principle" based decisions, and
actual current practices.Epidemiologic Perspectives & Innovations 2004, 1:2 http://www.epi-perspectives.com/content/1/1/2
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Exemplars, reconsiderations, and debates
We seek to acknowledge the best epidemiologic studies
and papers with articles that discuss what sets these stud-
ies apart from the rest: a "Best of Epidemiology" series.
Much of methods training involves finding the worst in a
study. We believe it would be useful to give students and
other epidemiologists examples of how to do epidemiol-
ogy well. What studies should we most want to emulate,
and why?
In a similar vein, we hope to receive submissions that
remind us about the historical foundations of epidemiol-
ogy: a "History of Epidemiology" series. What historical
studies, insights, or methodology are important for
understanding the field, and why, and which are simply
interesting enough to be worth highlighting? History-of-
science type analysis of our field, almost completely
absent from the history-and-philosophy-of-science litera-
ture, would be particularly welcome.
A complement to the "best of" and recounting of histori-
cal high-points is reanalysis of particular study results or
aspects of the field's literature more generally. Many sub-
stantive letters to the editor about published papers reflect
a full article's worth of analysis by the letter authors. But
those authors have little opportunity to publish that anal-
ysis, even when it has substantial practical or methodo-
logical importance; we encourage submission to EP&I of
such papers, whether or not a letter to the editor has been
published. We encourage authors to take advantage of the
speed of online publishing to submit re-analyses of
important findings for publication while the implications
of the original study are still being debated. (Important re-
analyses, based on either the original data or sometimes
merely what was published, need not be immediate, how-
ever, and can still be interesting years later.) Readers of the
health science literature may often find themselves asking
a question about a study's results beyond the few specifi-
cally addressed in the published reports. A new analysis
might be more relevant to a particular decision, or even
out-and-out more informative than the original publica-
tion.
Finally, we hope to publish "Point-Counterpoint" collec-
tions on single topics. Authors considering writing a coun-
terpoint (or simply a related point) to an EP&I article are
encouraged to contact us in advance to see if we might
solicit other related submissions to create a larger collec-
tion. Topics of particular interest to us, where we would
like to encourage the starting of point-counterpoint series,
include the usefulness of causal inference in epidemiology
and the scientific basis for a particular regulatory decision
(e.g., the U.S. Food and Drug Administration decisions to
ban phenylpropanolamine and ephedra). We especially
encourage students to suggest potential topics.
Wishful wish list?
We will grant that this is an ambitious research agenda.
Perhaps it will be years before journals (this one or others)
see articles on all these topics. But it is also possible that
the next 100 dissertations in the field will include chapters
that cover most of this ground. And perhaps those of us
well past our dissertations can contribute a few also. We
hope that asking (and providing a venue for publication)
will make this much more likely.
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